TrialKit enabled Optinose to gain more control over their EDC environment by providing them with a solution they could use in-house, removing their previous need for resource-heavy outsourced data management services.
Blog and News Posts
SISCAPA Assay Technologies, a leader in high-precision protein analytics, was searching for a smartphone-driven data collection solution for its studies gathering longitudinal health insights from participants via daily blood sampling. By partnering with CDS, they were able to execute their study that seamlessly united data from three distinct modalities.
CDx Diagnostics was seeking to identify an EDC platform for its registry studies that would allow them to transition away from manual processes. TrialKit enabled them to design and manage the study in-house with minimal assistance and reduce the burden on their sites with mobile app access.
The white label implementation of CDS’ downloadable mobile app, TrialKit, made it possible for a traditional EDC vendor to efficiently and rapidly deploy a mobile eConsent and ePRO/eCOA solution to support the remote patient data collection needs of their current and future clients.
FUEL Studios was in the market for a mobile, feature-rich EDC platform that could help them improve and modernize their clients’ data collection methods. They found TrialKit to be an optimal solution for accommodating their clients’ unique needs and workflows.
Acumen Healthcare Solutions needed a highly configurable EDC system that could be adapted to fit varying study workflows and requirements. TrialKit was selected out of several competitive systems as the most flexible, cost-effective solution that was suited for small CROs and multi-national sponsors alike.
When ICON GPHS sought out a clinical data management solution to replace Oracle Clinical, they discovered TrialKit fulfilled all of their requirements, including ease of use, access reliability, and customer support.
Oncotherapeutics, an oncology-focused CRO, was faced with extensive timelines and high costs to create complex studies, which was incredibly burdensome on their resources. TrialKit allowed them to migrate and launch their oncology studies in just a few days, and the plug-and-play nature of the platform drastically shortened the learning curve for the Oncotherapeutics team.